Table 13.
Treatment | Total | Day 1 | Day 3 | Day 7 | Day 14 | ||||
---|---|---|---|---|---|---|---|---|---|
N | N | % | N | % | N | % | N | % | |
Nepafenac group | 106 | 2 | 1.9 | 2 | 1.9 | 2 | 1.9 | 2 | 1.9 |
Placebo group | 105 | 0 | 0.0 | 1 | 1.0 | 9 | 8.6 | 9 | 8.6 |
P value | 0.5467 | 0.3974 | 0.2001 | 0.2236 |
NLMixed model P = 0.6151; main effect of treatment; failure defined as aqueous cells score ≥3 or aqueous flare score = 3 or ocular pain score ≥4